HAYLEY SOMMERS: Open Payments
NPI 1053929935 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,854 in 87 payments from 33 companies in 2025. Trend: 2023 $3,031 · 2024 $3,420 · 2025 $1,854
Food & beverage: $1,854
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $290 |
| Merck Sharp & Dohme LLC | 9 | $186 |
| Celgene Corporation | 9 | $176 |
| Gilead Sciences, Inc. | 5 | $123 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Janssen Biotech, Inc. | 3 | $82 |
| ABBVIE INC. | 3 | $76 |
| Incyte Corporation | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| PFIZER INC. | 3 | $59 |
Products named: REBLOZYL, KEYTRUDA, Trodelvy, Fabhalta, KISQALI, Xtandi, JAKAFI, Enhertu.
Industry payments across FL — which companies pay providers there.
